MEDVi Pricing Explained: First-Month Rate vs Refill Costs Compared

Last reviewed: September 4, 2026 Last updated: September 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

MEDVi uses a two-tier pricing model: a lower introductory rate the first month, then a higher standard refill price every month after. For semaglutide injection, the advertised first-month rate is $179, and the ongoing refill rate is $299 per month. For tirzepatide, the first month is $279, then $399 for refills. Over 12 months, semaglutide totals $3,468 (averaging $289/month), and tirzepatide totals $4,668 (averaging $389/month)—both figures are our calculation. PlexusDx charges a flat $189/month for semaglutide injection with no introductory discount or refill jump, totaling $2,268 over 12 months—$1,320 less annually than MEDVi's blended first-year cost. MEDVi's structure lowers the barrier to start but costs more once you refill; PlexusDx costs more the first month but less every month thereafter and over the full year.

At-a-glance: MEDVi vs PlexusDx pricing

MEDVi pricing verified September 4, 2026 via checkout at glp1.medvi.org. PlexusDx pricing current as of September 4, 2026.

MEDVi's two-tier pricing: what you pay first month vs every month after

MEDVi advertises an introductory first-month price, then charges a higher standard refill rate starting with your second order. Both figures were verified at checkout on September 4, 2026.

Semaglutide injection

• First month (introductory rate): $179
• Ongoing refills (standard rate): $299 per month
• 12-month total (our calculation): $179 + ($299 × 11) = $3,468, averaging $289/month over the first year

Tirzepatide (injection or oral)

• First month (introductory rate): $279
• Ongoing refills (standard rate): $399 per month
• 12-month total (our calculation): $279 + ($399 × 11) = $4,668, averaging $389/month over the first year

Semaglutide tablets (oral)

• First month (introductory rate): $249
• Ongoing refills (standard rate): $369 per month
• MEDVi applies an approximately $70 surcharge to oral tablets over injection pricing (verified September 4, 2026).

MEDVi includes the provider consult, medication, unlimited support, and shipping in each monthly price. Dose escalations do not change the monthly rate. Orders ship every four weeks. There is no contract; you may cancel before the next refill.

PlexusDx flat-rate pricing: same price every month

PlexusDx charges one all-inclusive rate from the first order through every refill—no introductory discount, no refill increase. Every price includes the online provider visit, prescription, compounded medication, and shipping; there is no membership fee.

Semaglutide injection

• Month-to-month: $189/month → $2,268 over 12 months
• 3-month commitment: $169/month → $2,028 over 12 months (prepaid per-month equivalent; our calculation)
• 6-month commitment: $149/month → $1,788 over 12 months (prepaid per-month equivalent; our calculation)

Tirzepatide injection

• Month-to-month: $289/month → $3,468 over 12 months
• 3-month commitment: $269/month → $3,228 over 12 months (prepaid per-month equivalent; our calculation)
• 6-month commitment: $249/month → $2,988 over 12 months (prepaid per-month equivalent; our calculation)

PlexusDx also offers semaglutide and tirzepatide in oral-capsule formulations and a microdose semaglutide injection protocol at $129/month for members interested in maintenance dosing. Oral options carry higher per-month rates than injections; current pricing is published on each product page before intake.

12-month cost comparison: introductory discount vs flat rate

The introductory rate creates a lower first-month cost but a higher total over 12 months compared to PlexusDx's flat rate.

All 12-month totals are our calculation. MEDVi figures reflect the first-month introductory rate plus 11 months at the standard refill rate. PlexusDx figures reflect the month-to-month rate; 3-month and 6-month commitment tiers reduce the annual cost further.

On a month-by-month basis after the introductory period, MEDVi's semaglutide refill ($299) is $110 more per month than PlexusDx's flat $189 rate, and MEDVi's tirzepatide refill ($399) is $110 more per month than PlexusDx's flat $289 rate. That $110/month difference compounds to $1,320 annually for semaglutide and $1,200 annually for tirzepatide (our calculation).

What the monthly price includes at each provider

MEDVi (verified September 4, 2026)

• Compounded semaglutide or tirzepatide (injection or oral)
• Online clinician consultation and prescription
• Unlimited support (care coaching, unlimited doctor calls, free dietitian visit referenced in comparison data)
• Shipping
• 4-week supply per order
• Same price at every dose level
• No membership fee on the compounded pathway (a $99/month membership applies to the branded Wegovy/Zepbound pathway, which carries separate medication costs)

PlexusDx

• Compounded semaglutide or tirzepatide (injection or oral capsule)
• Online provider visit and prescription
• Free check-in with a Doctor of Pharmacy
• Medication and shipping
• Same price at every dose level
• No membership fee, no hidden fees
• Optional genetics add-on ($99 for program members, $298 standalone); the genetics test does not select or predict medication—a licensed provider determines whether a prescription is appropriate

Decision factors: introductory rate vs ongoing cost

MEDVi's lower barrier to start

The $179 first-month rate for semaglutide is $10 less than PlexusDx's flat $189, and the $279 first-month rate for tirzepatide is $10 less than PlexusDx's $289. If upfront cost is the binding constraint and you are uncertain about committing beyond one month, MEDVi's introductory rate lowers the financial threshold to try the medication.

PlexusDx's lower ongoing and annual cost

Starting with the second order, PlexusDx's flat rate is $110/month less than MEDVi's refill rate for both semaglutide and tirzepatide. Over 12 months, that difference totals $1,320 for semaglutide and $1,200 for tirzepatide (our calculation). If you expect to refill for several months or a full year, the flat rate eliminates the refill jump and reduces total cost.

Pricing transparency

PlexusDx publishes all pricing—month-to-month and prepaid commitment tiers—on public product pages before intake. MEDVi displays pricing after you complete the health questionnaire (verified September 4, 2026). Both models show the final monthly rate before payment; the difference is when in the flow the figures become visible.

Prepaid commitment options

MEDVi offers 3-, 6-, and 12-month bundles with 0% financing (Klarna installments over 12 months) and added benefits (free care coaching, dietitian visit, unlimited doctor calls); bundles are non-refundable for unused months. The per-month rates for these bundles were not published in our verified sources. PlexusDx offers 3-month and 6-month commitment tiers at reduced per-month rates ($169 and $149 for semaglutide injection, $269 and $249 for tirzepatide injection), billed as prepaid blocks.

Review record

PlexusDx holds a 4.2-star rating on Trustpilot, with 76% of reviews at five stars and 81% at four stars or higher (captured September 4, 2026). We did not capture verified review data for MEDVi during this research cycle; readers comparing service quality should check Trustpilot, Reddit, and other independent platforms directly and note the capture date of any review summary.

Choose MEDVi if…

• You want the lowest possible first-month cost and are willing to accept a higher refill rate starting month two.
• You are uncertain about continuing beyond one month and prefer to minimize upfront financial commitment.
• You value bundled care coaching, dietitian visits, and unlimited clinician calls, and you are considering a prepaid multi-month bundle (verify the bundle per-month rate and refund policy at checkout).
• You prefer to see pricing after completing a health questionnaire rather than on a public page.

Choose PlexusDx if…

• You expect to refill for multiple months and want to minimize total cost over 12 months—PlexusDx's flat rate eliminates the refill jump and saves $1,320 annually on semaglutide, $1,200 on tirzepatide (our calculation, month-to-month comparison).
• You prefer transparent, published pricing visible before you start an intake.
• You want a single flat rate from the first order through every refill, with no introductory discount followed by a price increase.
• You are interested in a microdose maintenance protocol ($129/month) or oral-capsule formulations and want all options published on one site.
• You value a 4.2-star Trustpilot rating with 81% of reviews at four stars or higher (captured September 4, 2026).

Methodology and freshness

All MEDVi pricing was verified September 4, 2026 via completed intake and checkout at glp1.medvi.org. The $179 first-month and $299 refill rates for semaglutide injection, the $279/$399 rates for tirzepatide, and the $70 oral surcharge were captured directly from the ordering flow. PlexusDx pricing was verified September 4, 2026 from public product pages. The 12-month cost totals ($3,468 for MEDVi semaglutide, $2,268 for PlexusDx semaglutide month-to-month, and corresponding tirzepatide figures) are our calculation: we added the first-month introductory rate to eleven months at the refill rate for MEDVi, and multiplied the flat monthly rate by 12 for PlexusDx. The $1,320 and $1,200 annual differences are also our calculation. Pricing structures, included services, and cancellation terms were documented from primary sources dated September 4, 2026 and July 20, 2026. No promotional codes, affiliate discounts, or undocumented figures appear in this comparison. If you encounter a price at checkout that differs from the figures published here, we recommend confirming the rate with the provider's support team and noting whether the quote reflects an introductory rate, a refill rate, or a prepaid bundle before committing.

Frequently Asked Questions

Does MEDVi's $179 rate continue every month or is it only the first month?

The $179 rate for semaglutide injection is an introductory first-month price. Starting with your second order, MEDVi charges the standard refill rate of $299 per month. The same structure applies to tirzepatide: $279 first month, $399 for refills. Both figures were verified at checkout September 4, 2026.

How much do I save over 12 months choosing PlexusDx's flat rate instead of MEDVi's two-tier pricing?

For semaglutide injection, PlexusDx's month-to-month rate totals $2,268 over 12 months versus MEDVi's $3,468 (our calculation), a difference of $1,320. For tirzepatide, the totals are $3,468 with PlexusDx versus $4,668 with MEDVi, a difference of $1,200 (our calculation). PlexusDx's 3-month and 6-month commitment tiers further reduce the annual cost.

Does the price go up when my dose increases?

No. Both MEDVi and PlexusDx hold the monthly price constant regardless of dose level. At MEDVi, you pay the refill rate ($299 for semaglutide, $399 for tirzepatide) whether you are at 0.25 mg or 2.4 mg. At PlexusDx, you pay the same flat rate ($189 for semaglutide injection, $289 for tirzepatide injection, month-to-month) at every dose.

Are compounded semaglutide and tirzepatide FDA-approved?

No. Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Both MEDVi and PlexusDx offer compounded GLP-1 medications prepared by licensed compounding pharmacies. PlexusDx works with licensed 503A compounding pharmacies.

Can I cancel either program before the next refill if I need to stop?

Yes. Both MEDVi and PlexusDx operate on a cancel-anytime monthly subscription model with no contract (verified September 4, 2026). If you enroll in a prepaid multi-month bundle at MEDVi or a 3-month or 6-month commitment at PlexusDx, cancellation and refund terms differ; review the specific terms for prepaid plans at checkout before committing.

Sources

• PlexusDx internal comparison of MEDVi vs PlexusDx pricing and service models, captured July 20, 2026 and September 4, 2026
• PlexusDx public product pages for semaglutide injection, tirzepatide injection, and microdose GLP-1 protocol, accessed September 4, 2026
• MEDVi GLP-1 program page at glp1.medvi.org, accessed September 4, 2026
• MEDVi pricing captured via completed intake and checkout flow at glp1.medvi.org, September 4, 2026 13:49:55 UTC
• PlexusDx Trustpilot profile, 4.2-star rating (76% five-star, 81% four-star or higher), captured September 4, 2026
• MEDVi introductory and refill pricing verified through checkout, September 4, 2026 13:49:55 UTC

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.